We hope the following case studies will increase your understanding of the
work we do, as well as demonstrate our “made to measure” approach.

 Project positioning for financing of a start-up company
    in RNA technologies

 Clinical strategy in humans and animals for
    an oncology start-up company

 Commercial launch of a service company spun out from
    a big pharma

 Corporate strategy and development of a mature
    biotech company

 Restructuring of a research center and creation
    of a technology park

 Consideration of Entry in Europe to leverage
    partnering negotiations

 Detailed valuation of an almost-partnered clinical program
    in oncology

 Due diligence in human health for Blackstone to acquire
    a portfolio of mature products from Aventis

 Due diligence in animal health for CEVA acquired by
    ABN Amro

 Due diligence in human health for AXA Private Equity

 Due diligence in diagnostics for ABN Amro to acquire
    AES Laboratories

 Securing the corporate development of a vaccine business

 Early Access Program in Europe and financing
    of European subsidiary

 Support to a new player in the field of animal vaccine

 Strategy and implentation of a publicly listed US-based
    biotech in Europe

 Strategic positioning of a CMO and recommendation